Kevin Harris, MD, PhD| Kevin Harris, MD, PhD |
 |
 |
 Rank: Associate Professor Division: Hematology & Oncology Campus Address: SHEL 513 Mailing Address: 1720 2nd Avenue South, NP2540 Birmingham, AL 35294-3300 Phone: (205) 934-6995 Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it For an appointment, call (205) 934-9999 or toll free 1 (800) UAB-8816. Departmental Affiliation(s): Primary: Medicine Medical School: University of Oklahoma Health Sciences Center, Oklahoma City Internal Medicine Residency: University of Minnesota, Minneapolis Fellowship: Hematology/Oncology, University of Minnesota, Minneapolis Other Education: PhD in Biochemistry: University of Oklahoma Health Sciences Center, Oklahoma City Clinical Interests Dr. Harris is a hematologist with clinical interests in benign hematology, particularly hemostasis and thrombosis. His research interests involve the role of inflammatory cytokines in cancer, and the biology of tumor microparticles. He is also active in human research ethics. Selected Publications 1. Burns S, Arcasoy A, Li L, Kurian E, Selander K, Emanuel P, and Harris KW. Purification and characterization of the yeast-expressed erythropoietin mutant Epo (R103A), a specific inhibitor of human primary hematopoietic cell erythropoiesis. Blood 99 (12):4400-4405, 2002. 2. Selander KS*, Li L* 1, Watson L *, Merrell M, Dahmen H, C. Heinrich PC, Müller-Newen G, and Harris KW. Inhibition of cytokine receptor gp130 signaling in breast cancer cells blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Research 64:6924-6933, 2004. (*authors contributed equally). 3. Ilvesaro JM, Merrell MA, Graves D, Rahko E, Jukkola-Vuorinen A, Vuopala KS, Harris KW, and Selander KS. TLR9 mediates CpG-oligonucleotide-induced cellular invasion. Mol Cancer Res 2008;6(10), 2008 Publications: See a listing of publications on PubMed, a service of the National Library of Medicine. |